Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

11.00
Delayed Data
As of Jul 31
 -0.05 / -0.45%
Today’s Change
3.96
Today|||52-Week Range
11.40
+126.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.1M5.4M6.0M7.6M
 
 
 
 
 
Cost of Goods Sold1.9M1.9M2.5M2.7M
 
 
 
 
 
Depreciation And Amortization418.4K402.5K417.2K446.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M3.1M3.1M4.4M
 
 
 
 
 
General Expenses3.4M2.8M3.1M4.7M
 
 
 
 
 
Research And Development1.7M917.6K1.2M2.2M
 
 
 
 
 
Total Operating Expenses5.7M5.1M6.0M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-632.7K245.0K-19.6K-206.4K
 
 
 
 
 
Interest Expense On Debt86.0K78.2K69.6K60.7K
 
 
 
 
 
Other Expenses7.0K8.1K281.9K-3.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-696.7K192.2K205.3K-255.5K
 
 
 
 
 
Income Taxes-287.2K-102.6K-87.9K-88.3K
 
 
 
 
 
Net Income-409.5K89.5K117.4K-167.2K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M3.0M3.0M3.0M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M3.1M3.1M3.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14$0.03$0.04-$0.06
 
 
 
 
 
EPS Diluted-$0.14$0.03$0.04-$0.06